Polymeric nanomedicine for cancer MR imaging and drug delivery

被引:142
作者
Khemtong, Chalermchai [1 ]
Kessinger, Chase W. [1 ]
Gao, Jinming [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
IRON-OXIDE NANOPARTICLES; PEGYLATED LIPOSOMAL DOXORUBICIN; MESOPOROUS SILICA NANOPARTICLES; PLURONIC((R)) BLOCK-COPOLYMERS; GLYCOL CHITOSAN NANOPARTICLES; NONVIRAL GENE DELIVERY; SMALL INTERFERING RNA; CONTRAST AGENTS; IN-VIVO; PARACEST AGENTS;
D O I
10.1039/b821865j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Multifunctional nanomedicine is emerging as a highly integrated platform that allows for molecular diagnosis, targeted drug delivery, and simultaneous monitoring and treatment of cancer. Advances in polymer and materials science are critical for the successful development of these multi-component nanocomposites in one particulate system with such a small size confinement (<200 nm). Currently, several nanoscopic therapeutic and diagnostic systems have been translated into clinical practice. In this feature article, we will provide an up-to-date review on the development and biomedical applications of nanocomposite materials for cancer diagnosis and therapy. An overview of each functional component, i.e. polymer carriers, MR imaging agents, and therapeutic drugs, will be presented. Integration of different functional components will be illustrated in several highlighted examples to demonstrate the synergy of the multifunctional nanomedicine design.
引用
收藏
页码:3497 / 3510
页数:14
相关论文
共 143 条
  • [41] Artificial reporter gene providing MRI contrast based on proton exchange
    Gilad, Assaf A.
    McMahon, Michael T.
    Walczak, Piotr
    Winnard, Paul T., Jr.
    Raman, Venu
    van Laarhoven, Hanneke W. M.
    Skoglund, Cynthia M.
    Bulte, Jeff W. M.
    van Zijl, Peter C. M.
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (02) : 217 - 219
  • [42] A combinatorial polymer library approach yields insight into nonviral gene delivery
    Green, Jordan J.
    Langer, Robert
    Anderson, Daniel G.
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2008, 41 (06) : 749 - 759
  • [43] Effective drug delivery by PEGylated drug conjugates
    Greenwald, RB
    Choe, YH
    McGuire, J
    Conover, CD
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (02) : 217 - 250
  • [44] Macromolecular therapeutics - Advantages and prospects with special emphasis on solid tumour targeting
    Greish, K
    Fang, J
    Inutsuka, T
    Nagamitsu, A
    Maeda, H
    [J]. CLINICAL PHARMACOKINETICS, 2003, 42 (13) : 1089 - 1105
  • [45] Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells
    Guo, S
    Huang, F
    Guo, P
    [J]. GENE THERAPY, 2006, 13 (10) : 814 - 820
  • [46] NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
    Hamaguchi, T
    Matsumura, Y
    Suzuki, M
    Shimizu, K
    Goda, R
    Nakamura, I
    Nakatomi, I
    Yokoyama, M
    Kataoka, K
    Kakizoe, T
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (07) : 1240 - 1246
  • [47] Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer
    Hamoudeh, Misara
    Kamleh, Muhammad Anas
    Diab, Roudayna
    Fessi, Hatem
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (12) : 1329 - 1346
  • [48] Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging
    Hartman, Keith B.
    Laus, Sabrina
    Bolskar, Robert D.
    Muthupillai, Raja
    Helm, Lothar
    Toth, Eva
    Merbach, Andre E.
    Wilson, Lon J.
    [J]. NANO LETTERS, 2008, 8 (02) : 415 - 419
  • [49] Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin alpha(v)beta(3) antagonists
    Haubner, R
    Gratias, R
    Diefenbach, B
    Goodman, SL
    Jonczyk, A
    Kessler, H
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (32) : 7461 - 7472
  • [50] Högemann-Savellano D, 2003, NEOPLASIA, V5, P495